Literature DB >> 11865067

Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.

Jynho Kim1, Ricardo A Feldman.   

Abstract

The c-fps/fes proto-oncogene encodes a 92-kDa protein tyrosine kinase that is preferentially expressed in myeloid and endothelial cells. Fes is believed to play a role in vascular development and myelopoiesis and in the inflammatory responses of granulocytes and macrophages. To help define the biological role of this kinase and identify its downstream targets, we have developed a gain-of-function allele of Fes that has potent biological activity in myeloid cell progenitors. Introduction of constitutively active Fes into bipotential U937 cells induced the appearance of fully differentiated macrophages within 6 to 12 days. The Fes-expressing differentiated cells became adherent, had distinctive macrophage morphology, and exhibited increased expression of myelomonocytic differentiation markers, including CD11b, CD11c, CD18, CD14, and the macrophage colony-stimulating factor receptor. These cells acquired phagocytic properties and exhibited NADPH oxidase and nonspecific esterase activities, confirming that they were functionally active macrophages. Concomitantly, there was downregulation of the granulocytic marker granulocyte colony-stimulating factor receptor, indicating that the biological activity of Fes was coordinated in a lineage-specific manner. A constitutively active Src did not induce macrophage morphology or upregulation of myelomonocytic markers in U937 cells, suggesting that the biological activity we observed was not a general consequence of expression of an activated nonreceptor tyrosine kinase. Analysis of possible downstream targets of Fes revealed that this kinase activated the ets family transcription factor PU.1, which is essential for macrophage development. Our results strongly implicate Fes as a key regulator of terminal macrophage differentiation and identify PU.1 as a transcription factor that may mediate some of its biological activities in myeloid cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11865067      PMCID: PMC135606          DOI: 10.1128/MCB.22.6.1903-1918.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  84 in total

1.  Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation.

Authors:  J M Pongubala; C Van Beveren; S Nagulapalli; M J Klemsz; S R McKercher; R A Maki; M L Atchison
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

2.  The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3'-kinase.

Authors:  P H Stein; J D Fraser; A Weiss
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

3.  The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter.

Authors:  H L Pahl; R J Scheibe; D E Zhang; H M Chen; D L Galson; R A Maki; D G Tenen
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

4.  Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines.

Authors:  T Torigoe; R O'Connor; D Santoli; J C Reed
Journal:  Blood       Date:  1992-08-01       Impact factor: 22.113

5.  Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.

Authors:  K B Bibbins; H Boeuf; H E Varmus
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

6.  JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region.

Authors:  F W Quelle; N Sato; B A Witthuhn; R C Inhorn; M Eder; A Miyajima; J D Griffin; J N Ihle
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

7.  c-fps/fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3.

Authors:  Y Hanazono; S Chiba; K Sasaki; H Mano; A Miyajima; K Arai; Y Yazaki; H Hirai
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

8.  Granulocyte macrophage-colony stimulating factor stimulates both association and activation of phosphoinositide 3OH-kinase and src-related tyrosine kinase(s) in human myeloid derived cells.

Authors:  S Corey; A Eguinoa; K Puyana-Theall; J B Bolen; L Cantley; F Mollinedo; T R Jackson; P T Hawkins; L R Stephens
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

9.  Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiation.

Authors:  R Manfredini; A Grande; E Tagliafico; D Barbieri; P Zucchini; G Citro; G Zupi; C Franceschi; U Torelli; S Ferrari
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

10.  Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites.

Authors:  N Mackman; K Brand; T S Edgington
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  8 in total

1.  The KRAB-associated co-repressor KAP-1 is a coiled-coil binding partner, substrate and activator of the c-Fes protein tyrosine kinase.

Authors:  Frank J Delfino; Jonathan M Shaffer; Thomas E Smithgall
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

2.  Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.

Authors:  Shengnan Zhang; Violeta Chitu; E Richard Stanley; Bruce E Elliott; Peter A Greer
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

3.  Small-molecule inhibitors of the c-Fes protein-tyrosine kinase.

Authors:  Sabine Hellwig; Chandra V Miduturu; Shigeru Kanda; Jianming Zhang; Panagis Filippakopoulos; Eidarus Salah; Xianming Deng; Hwan Geun Choi; Wenjun Zhou; Wooyoung Hur; Stefan Knapp; Nathanael S Gray; Thomas E Smithgall
Journal:  Chem Biol       Date:  2012-04-20

4.  Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages.

Authors:  Tomohiko Tamura; Pratima Thotakura; Tetsuya S Tanaka; Minoru S H Ko; Keiko Ozato
Journal:  Blood       Date:  2005-06-09       Impact factor: 22.113

5.  Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.

Authors:  Kevin Stoltz; Maksim Sinyuk; James S Hale; Qiulian Wu; Balint Otvos; Kiera Walker; Amit Vasanji; Jeremy N Rich; Anita B Hjelmeland; Justin D Lathia
Journal:  Neuro Oncol       Date:  2014-11-21       Impact factor: 12.300

6.  Bimolecular fluorescence complementation demonstrates that the c-Fes protein-tyrosine kinase forms constitutive oligomers in living cells.

Authors:  Jonathan M Shaffer; Sabine Hellwig; Thomas E Smithgall
Journal:  Biochemistry       Date:  2009-06-09       Impact factor: 3.162

7.  Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis.

Authors:  Tom van der Wel; Riet Hilhorst; Hans den Dulk; Tim van den Hooven; Nienke M Prins; Joost A P M Wijnakker; Bogdan I Florea; Eelke B Lenselink; Gerard J P van Westen; Rob Ruijtenbeek; Herman S Overkleeft; Allard Kaptein; Tjeerd Barf; Mario van der Stelt
Journal:  Nat Commun       Date:  2020-06-25       Impact factor: 14.919

8.  Natural feline coronavirus infection: differences in cytokine patterns in association with the outcome of infection.

Authors:  Anja Kipar; Marina L Meli; Klaus Failing; Tatjana Euler; Maria A Gomes-Keller; Dirk Schwartz; Hans Lutz; Manfred Reinacher
Journal:  Vet Immunol Immunopathol       Date:  2006-04-18       Impact factor: 2.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.